Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05417334

Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.

Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum: Randomised Prospective Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 9 months postpartum.

Detailed description

Dyspareunia is a type of genito-pelvic pain (GPP) that takes place during vaginal penetration at some point in sexual intercourse. It greatly affects quality of life as well as psychological and sexual wellbeing. A delivery with episiotomy, perineal tearing or labor dystocia using forceps or vacuum, are risk factors that contribute to the appearance of de novo dyspareunia with a prevalence of 17-45% at 6 months postpartum. There is no evidence in the scientific literature of the effect of radiofrequency is this group of patients, however there is a clinical trial that describes the effect in scar tissue although not in the perineum. It is for all of the above that the following project is proposed, to evaluate the effect of RF in perineal healing and vaginal trigger points caused as a consequence of GPP. The main objective of this study is to evaluate the role that radiofrequency (RF) plays in reducing the level of pain in de novo dyspareunia in postpartum women that persists from 4 to 9 months.

Conditions

Interventions

TypeNameDescription
DEVICEResistive Capicitive Monopolar Radiofrequency5 Radiofrequency sessions including the abdominal region, the vulva and pelvic floor tissue and Thiele massage done daily by the patient at home

Timeline

Start date
2021-03-18
Primary completion
2025-12-01
Completion
2026-01-01
First posted
2022-06-14
Last updated
2025-12-09

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05417334. Inclusion in this directory is not an endorsement.